Cingulate Stock (NASDAQ: CING) stock price, news, charts, stock research, profile.
Open | $0.33 |
Close | $0.34 |
Volume / Avg. | 248.11K / 503.68K |
Day Range | 0.32 - 0.34 |
52 Wk Range | 0.28 - 16.39 |
Market Cap | $3.09M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 38 |
Short Interest | 2.38% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Cingulate (NASDAQ:CING) through any online brokerage.
Other companies in Cingulate’s space includes: NovaBay Pharmaceuticals (AMEX:NBY), Processa Pharma (NASDAQ:PCSA), cbdMD (AMEX:YCBD), 60 Degrees (NASDAQ:SXTP) and MyMD Pharmaceuticals (NASDAQ:MYMD).
There is no analysis for Cingulate.
Cingulate has a consensus price target of $8.50.
The stock price for Cingulate (NASDAQ: CING) is $0.33 last updated July 19, 2024 at 5:38 PM EDT.
There are no upcoming dividends for Cingulate.
Cingulate’s Q2 earnings are confirmed for Monday, August 12, 2024.
There is no upcoming split for Cingulate.
Cingulate is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.